Kelvin Yong
About Kelvin Yong
Kelvin Yong is the Associate Director of DSD-CTS at Bristol-Myers Squibb, with over 15 years of experience in the pharmaceutical industry, specializing in drug substance development and clinical trial supply.
Title
Kelvin Yong is currently the Associate Director, DSD-CTS at Bristol-Myers Squibb in Summit, NJ.
Career in Pharmaceutical Industry
Kelvin Yong has over 15 years of experience in the pharmaceutical industry, specifically focusing on drug substance development and clinical trial supply. He has held various positions at Merck, Celgene, and Schering-Plough Research Institute, contributing to his extensive expertise in the field.
Positions at Celgene
Kelvin Yong held several key roles at Celgene in Summit, NJ. He began as a Senior Scientist from 2011 to 2016, then advanced to Principal Scientist from 2016 to 2017. He was subsequently promoted to Senior Manager of DSD-CTS, a role he held from 2017 to 2019, and finally served as Associate Director in 2019 for one month.
Educational Background
Kelvin Yong completed his B.Sc. in Biochemistry and Chemistry at the University of Toronto, followed by an M.Sc. in Chemistry from Brock University. He then pursued a Ph.D. in Chemistry at the University of Waterloo from 1998 to 2002. Additionally, he completed an NSERC Postdoctoral Fellowship at Stanford University from 2002 to 2005.
Expertise in Chemical Process Development
Kelvin Yong possesses extensive expertise in chemical process development and scale-up for clinical and commercial manufacturing. His background also includes strong regulatory compliance and quality assurance within the pharmaceutical sector. He actively contributes to cross-functional teams, driving innovation and efficiency in drug development processes.